Skip to main content
. 2022 Oct 12;26(12):2579–2584. doi: 10.1007/s11605-022-05463-1

Table 1.

Comparison of demographic and pre-operative clinical data between patients who were found to have a non-complete versus a complete pathological response

pNCR group
n/mean/median (%/SD)
n = 128
pCR group
n/mean/median (%/SD)
n = 44
p
Male sex 83 (64.8%) 29 (65.9%) 0.99
Age (years) 59.3 (12) 58.3 (12.5) 0.64
Body mass index (kg/m2) 26.5 (4.6) 26.8 (5.4) 0.69
ASA 0.78
  1 1 (0.8%) 1 (2.2%)
  2 77 (60.1%) 23 (52.3%)
  3 50 (39.1%) 18 (40.9)
Clinical T
  2 22 (17.2%) 7 (15.9%) 0.46
  3 81 (63.2%) 32 (72.3%)
  4 24 (18.7%) 5 (11.3%)
Clinical N 0.52
  0 40 (31.2%) 15 (34.1%)
  1 75 (58.5%) 27 (61.3%)
  2 13 (10.1%) 2 (4.5%)
Positive CRM (MRI) 54 (42.1%) 17 (38.6%) 0.72
Tumor location 0.35
  Low 67 (52.3%) 18 (40.9%)
  Mid 56 (38.9%) 21 (47.7%)
  High 6 (4.6%) 4 (9.1%)
Tumor size (cm) 4.8 (1.7) 4.6 (2) 0.57
Extramural vascular invasion 29 (22.6%) 4 (9.1%) 0.07
Tumor shape 0.46
  Polypoid 8 (6.2%) 5 (11.4%)
  Semicircular 61 (47.6%) 19 (43.2%)
  Annular 45 (35.1%) 13 (29.5%)
Tumor grade 0.69
  Low 105 (82%) 21 (47.7%)
  High 13 (10.2%) 1 (2.2%)
Sphincter involvement
  Internal 27 (21%) 7 (15.9%) 0.51
  External 7 (5.4%) 1 (2.2%) 0.68
Symptomatic presentation 0.09
  Obstruction 9 (7%) 0 (0%)
  Bleeding 75 (58.6%) 21 (47.7%)
  Pain 4 (3.1%) 4 (9.1%)

ASA, American Society of Anesthesiologists; CRM, circumferential resection margin; MRI, magnetic resonance imaging; pNCR, pathological non-complete response; pCR, pathological complete response